SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories informs about analyst meet

02 Feb 2023 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015, Neuland Laboratories has informed that it will announce its results for the third quarter and nine months ended December 31, 2022 on February 13, 2023. The results will also be made available on the website of the Company, www.neulandlabs.com. Following the announcement, the management of the Company will host an Earnings Call on February 14, 2023 at 16:30 hrs.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

17177.50 225.25 (1.33%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: